| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 22, 2006
From the Deep South Center on Effectiveness Research (D.A.L., C.I.K., J.J.A.), Birmingham VA Medical Center, Ala; the Department of Medicine (D.A.L., C.I.K., O.D.W., J.J.A.), University of Alabama at Birmingham, Ala; the Department of Biostatistics (G.H.), University of Alabama at Birmingham School of Public Health, Ala; and the Department of Epidemiology (V.J.H.), University of Alabama at Birmingham School of Public Health, Ala. * To whom correspondence should be addressed. E-mail: dlevine{at}uab.edu.
Background and Purpose--Medication access is crucial to secondary stroke prevention. We assessed medication access and associated barriers to care across region and time in a national sample of US stroke survivors. Methods--Among all 5840 black or white stroke survivors aged Results--In 2004, Conclusions--We identified a vulnerable stroke survivor population with reduced medication access and increased barriers to medical care. Membership in this population has grown substantially from 1997 to 2004, potentially leading to increased recurrent stroke incidence.
Accepted on December 12, 2006
Reduced Medication Access. A Marker for Vulnerability in US Stroke Survivors
Deborah A. Levine MD, MPH*;
45 years responding to the National Health Interview Survey years 1997 to 2004, we examined inability to afford medications within the last 12 months across region (Northeast, Midwest, West, South) and time. With logistic regression, we adjusted associations between medication inaffordability and region and time for age, sex, race, neurological disability, comorbidity, health status, insurance, income and out-of-pocket medical expenses.
76 000 US stroke survivors were unable to afford medications. Lower medication affordability was reported among stroke survivors who were <65 years old, black, female, had high comorbidity or low health status. Compared with stroke survivors able to afford medications, those unable more frequently reported lack of transportation (15% versus 3%; P<0.001), no health insurance (16% versus 3%; P<0.001), no usual place of care (6% versus 2%; P=0.001), income <$20 000 (66% versus 40%; P<0.001) and out-of-pocket medical expenses
$2000 (35% versus 25%; P<0.001). From 1997 to 2004, inability to afford medications increased significantly from 8.1% to 12.7% (Ptrend=0.01) overall and increased in all US regions except the Northeast.
Related Article:
Stroke 2007 38: 1427-1429.
This article has been cited by other articles:
![]() |
K. Asplund Stroke in the Uninsured Stroke, June 1, 2009; 40(6): 1950 - 1951. [Full Text] [PDF] |
||||
![]() |
L. H. Kuller So, What's New? Stroke, May 1, 2007; 38(5): 1427 - 1429. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |